[A nomogram model for predicting MACE risk following primary percutaneous coronary intervention in STEMI patients: an exploratory study based on serum GSDMD]. [PDF]
Hu X +6 more
europepmc +1 more source
[Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies]. [PDF]
Chu J +6 more
europepmc +1 more source
[Shihu Mixture alleviates diabetic cardiomyopathy in rats by Sirt3-mediated upregulation of myocardial mitochondrial mitophagy pathway]. [PDF]
Lin X, He Y, Shi H, Liu J, Hu H.
europepmc +1 more source
[Effects of polyvinyl alcohol-boric acid-based functionalized hydrogels on HSFs and HaCaT cells]. [PDF]
Song W +13 more
europepmc +1 more source
[β‑blockers after percutaneous coronary intervention does not reduce risks of all-cause mortality or major adverse cardiovascular events in patients with stable coronary artery disease]. [PDF]
Gao X +7 more
europepmc +1 more source
[Research progress on calcification mechanism and anti-calcification strategies of vascular grafts]. [PDF]
Su X, Qiu F, Wang H, Han Q.
europepmc +1 more source
[Guidelines for the diagnosis and management of first relapsed multiple myeloma in China (2026)]. [PDF]
Plasma Cell Disease Group +3 more
europepmc +1 more source
[Development and Validation of a Risk Prediction Model for Secondary Pulmonary Infarction in Elderly Patients With Acute Pulmonary Embolism]. [PDF]
Chen S, Weng M, Lü Y, Jiang Y, Pang Y.
europepmc +1 more source
[Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report]. [PDF]
Tang X +8 more
europepmc +1 more source
[Application of Kartogenin in cartilage tissue engineering]. [PDF]
Jiang J, Zhang S, Lu W.
europepmc +1 more source

